XML 62 R56.htm IDEA: XBRL DOCUMENT v3.22.2.2
Non-financial Assets and Liabilities - Summary of Carrying Value of In Process Research and Development Acquired by Product (Details) - USD ($)
$ in Thousands
Sep. 30, 2022
Jun. 30, 2022
Jun. 30, 2021
Disclosure Of Intangible Assets [Line Items]      
Carrying value of in process research and development $ 578,275 $ 578,652 $ 580,546
In-process Research and Development Acquired      
Disclosure Of Intangible Assets [Line Items]      
Carrying value of in process research and development 427,779 427,779 $ 427,779
In-process Research and Development Acquired | Cardiovascular Products      
Disclosure Of Intangible Assets [Line Items]      
Carrying value of in process research and development 254,351 254,351  
In-process Research and Development Acquired | Intravenous Products      
Disclosure Of Intangible Assets [Line Items]      
Carrying value of in process research and development 70,730 70,730  
In-process Research and Development Acquired | MSC Products      
Disclosure Of Intangible Assets [Line Items]      
Carrying value of in process research and development $ 102,698 $ 102,698